10-QFiling Date: May 1, 2026

Moderna (MRNA) 10-Q (May 1, 2026)

mrna-20260331

View SEC Filing

ACC: 0001682852-26-000060

Key Financial Metrics3M Mar'26 · 2026-03-31

Revenue$389.0M

Net Income-$1.34B

Total Assets$11.49B

Stockholders' Equity$7.41B

Operating Cash Flow-$630.0M

More filings from Moderna (MRNA)

Recent 10-Q filings from other companies

Lennar 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-31 · Rev $8.0B, NI $283.9M
Nike (NKE) 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-31 · Rev $11.2B, NI $712.0M
Darden Restaurants (DRI) 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-30 · Rev $3.2B, NI $233.4M
Mccormick & (MKC) 10-Q · Oct 1, 2026Quarterly Report · ended 2026-08-31 · Rev $5.8B, NI $97.6M
Conagra Brands (CAG) 10-Q · Sep 30, 2026Quarterly Report · ended 2026-08-30 · Rev $2.6B, NI $174.3M